Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction.

C de Zwaan, G M Willems, F Vermeer, J Res, F W Verheugt, A van der Laarse, M L Simoons, J Lubsen, W T Hermens

Department of Biophysics, University of Limburg, Maastricht, The Netherlands.

The activity of alpha-hydroxybutyrate dehydrogenase, creatine kinase, creatine kinase MB and aspartate aminotransferase was measured on serial plasma samples from patients with acute myocardial infarction. The study was part of a multicentre randomised trial of the effect of thrombolytic treatment in the acute phase of acute myocardial infarction. The applicability and comparability of enzyme tests for the estimation of myocardial injury were studied in 76 control patients and 74 patients treated with streptokinase. Treatment with streptokinase caused a considerable acceleration of enzyme release after acute myocardial infarction, both in patients with persistent coronary occlusion and in those with successful reperfusion. But this changed pattern of enzyme release did not affect the rate of enzyme elimination from plasma or the released proportions of different enzymes. Thus the assessment of infarct size by measurement of these enzyme activities can also be applied to patients treated with streptokinase. Moreover, the enzymes measured in the present study are all equally valid markers of myocardial injury.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Gibbons, R. J., Valeti, U. S., Araoz, P. A., Jaffe, A. S. (2004). The quantification of infarct size. J Am Coll Cardiol 44: 1533-1542 [Abstract] [Full Text]  
• Zijlstra, F., Ernst, N., de Boer, M.-J., Nibbering, E., Suryapranata, H., Hoorntje, J. C. A., Dambrink, J.-H. E., van't Hof, A. W. J., Verheugt, F. W. A. (2002). Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction. J Am Coll Cardiol 39: 1733-1737 [Abstract] [Full Text]  
• Liem, A., Zijlstra, F., Ottervanger, J. P., Hoorntje, J. C. A., Suryapranata, H., de Boer, M.-J., Verheugt, F. W. A. (2000). High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. J Am Coll Cardiol 35: 600-604 [Abstract] [Full Text]  
• Matetzky, S., Freimark, D., Chouraqui, P., Novikov, I., Agranat, O., Rabinowitz, B., Kaplinsky, E., Hod, H. (1998). The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion. J Am Coll Cardiol 32: 1326-1330 [Abstract] [Full Text]  
• Liem, A. L., van 't Hof, A. W. J., Hoorntje, J. C. A., de Boer, M.-J., Suryapranata, H., Zijlstra, F. (1998). Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 32: 629-633 [Abstract] [Full Text]